Sam Kongsamut
Nessuna posizione attualmente
Profilo
Dr. Sam Kongsamut is Executive Director-Pharmacology Division at Neurotrope, Inc.
Dr. Kongsamut was previously employed as a Director-External Innovation by Sanofi.
He received his doctorate degree from The University of Chicago.
Precedenti posizioni note di Sam Kongsamut
| Società | Posizione | Fine |
|---|---|---|
| SANOFI | Corporate Officer/Principal | - |
| NEUROTROPE, INC. | Corporate Officer/Principal | - |
Formazione di Sam Kongsamut
| The University of Chicago | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SANOFI | Health Technology |
| Aziende private | 1 |
|---|---|
Neurotrope, Inc.
 Neurotrope, Inc. Pharmaceuticals: MajorHealth Technology Neurotrope, Inc. is a biopharmaceutical company, which engages in the pre-clinical and clinical development of its product candidates. The company focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. It also develops bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X and Niemann-Pick Type C. The company was founded on January 11, 2011 and is headquartered in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- Sam Kongsamut
